Perioperative and long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision: a retrospective study of 672 patients.
Laparoscopic approach
Oncological outcomes
Rectal cancer
Robotic approach
Total mesorectal excision
Journal
Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401
Informations de publication
Date de publication:
30 Mar 2024
30 Mar 2024
Historique:
received:
06
03
2024
accepted:
24
03
2024
medline:
30
3
2024
pubmed:
30
3
2024
entrez:
30
3
2024
Statut:
epublish
Résumé
Although there's growing information about the long-term oncological effects of robotic surgery for rectal cancer, the procedure is still relatively new. This study aimed to assess the long-term oncological results of total mesorectal excision (TME) performed laparoscopically versus robotically in the setting of rectal cancer. Restrospective analysis of a prospectively maintained database. A total of 489 laparoscopic (L-TME) and 183 robotic total mesorectal excisions (R-TME) were carried out by a single surgeon between 2013 and 2023. The groups were compared in terms of perioperative and long-term oncological outcomes. In the R-TME and L-TME groups, male sex predominated (75.4% and 57.3%, respectively), although the robotic group was significantly greater (p = 0.008). There was no conversion in R-TME group, whereas three (0.6%) converted to open surgery in L-TME group. The R-TME group had a statistically significant higher number of distal rectal tumors (85%) compared to the L-TME group (54.6%). Only three (1.7%) patients in the R-TME group received abdomineperineal resection (APR); in contrast, 25 (5%) patients in the L-TME group received APR (p < 0.001). For R-TME, the mean follow-up was 70.7 months (range 18-138) and for L-TME, it was 60 months (range 14-140). Frequency of completed mesorectum was significantly greater in R-TME group (98.9% vs 94.2%, p < 0.001). The 5 year overall survival rates for R-TME and L-TME groups were 89.6% and 88.7%, respectively. The 5 year disease-free survival for R-TME and L-TME groups were 84.1% and 81.1%, respectively. The local recurrences rates were 7.6% and 6.3%, respectively in R-TME and L-TME groups (p = 0.274). R-TME is characterized by no conversion and improved mesorectal integrity. R-TME had longer operation time. The long-term oncological outcomes were comparable between groups.
Identifiants
pubmed: 38554211
doi: 10.1007/s11701-024-01922-w
pii: 10.1007/s11701-024-01922-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
144Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.
Références
Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482
doi: 10.1016/S0140-6736(86)91510-2
pubmed: 2425199
Guillou PJ, Quirke P, Thorpe H et al (2005) Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365(9472):1718–1726
doi: 10.1016/S0140-6736(05)66545-2
pubmed: 15894098
Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW et al (2010) Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11(7):637–645
doi: 10.1016/S1470-2045(10)70131-5
pubmed: 20610322
Huang M-J, Liang J-L, Wang H et al (2011) Laparoscopic assisted versus open surgery for rectal cancer: a meta-analysis of randomized controlled trials on oncologic adequacy of resection and long-term oncologic outcomes. Int J Colorectal Dis 26:415–421
doi: 10.1007/s00384-010-1091-6
pubmed: 21174107
Ng SSM, Lee JFY, Yiu RYC et al (2014) Long-term oncologic outcomes of laparoscopic versus open surgery for rectal cancer: a pooled analysis of 3 randomized controlled trials. Ann Surg 259:139–147
doi: 10.1097/SLA.0b013e31828fe119
pubmed: 23598381
Park EJ, Cho MS, Baek SJ et al (2015) Long-term oncologic outcomes of robotic low anterior resection for rectal cancer: a comparative study with laparoscopic surgery. Ann Surg 261:129–137
doi: 10.1097/SLA.0000000000000613
pubmed: 24662411
Corcione F, Esposito C, Cuccurullo D et al (2005) Advantages and limits of robot-assisted laparoscopic surgery: preliminary experience. Surg Endosc 19:117–119
doi: 10.1007/s00464-004-9004-9
pubmed: 15549629
Bademler S, Koza KB, Ucuncu MZ, Tokmak H, Bakir B, Oral EN et al (2019) Standardized laparoscopic sphincter-preserving total mesorectal excision for rectal cancer: median of 10 years’ long-term oncologic outcome in 217 unselected consecutive patients. Surg Laparosc Endosc Percutan Tech 29:354–361
doi: 10.1097/SLE.0000000000000664
pubmed: 31107850
Aliyev V, Tokmak H, Goksel S, Guven K, Bakir B, Kay H et al (2020) Robotic sphincter-saving total mesorectal excision for rectal cancer treatment: a single-surgeon experience in 103 consecutive male patients. Surg Technol Int 37:93–98
pubmed: 32634247
Aliyev V, Tokmak H, Goksel S, Meric S, Acar S, Kaya H et al (2020) The long-term oncological outcomes of the 140 robotic sphincter-saving total mesorectal excision for rectal cancer: a single surgeon experience. J Robot Surg 14:655–661
doi: 10.1007/s11701-019-01037-7
pubmed: 31811567
Weiser MR (2018) AJCC 8th edition: colorectal cancer. Ann Surg Oncol 25:1454–1455
doi: 10.1245/s10434-018-6462-1
pubmed: 29616422
Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J et al (2009) Efect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828
doi: 10.1016/S0140-6736(09)60485-2
pubmed: 19269520
pmcid: 2668948
Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH, Pathology Review C et al (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–357
doi: 10.1097/00000478-200203000-00009
pubmed: 11859207
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A et al (2010) Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the international study group of rectal cancer. Surgery 147:339–351
doi: 10.1016/j.surg.2009.10.012
pubmed: 20004450
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349
doi: 10.1016/j.jclinepi.2007.11.008
van der Pas MH, Haglind E, Cuesta MA et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. https://doi.org/10.1016/S1470-2045(13)70016-0
doi: 10.1016/S1470-2045(13)70016-0
pubmed: 23395398
Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA et al (2019) Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg 269(4):589–595. https://doi.org/10.1097/SLA.0000000000003002
doi: 10.1097/SLA.0000000000003002
pubmed: 30080730
Stevenson ARL, Solomon MJ, Lumley JW et al (2015) Efect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the AlaCart randomized clinical trial. JAMA 314(13):1356–1363
doi: 10.1001/jama.2015.12009
pubmed: 26441180
Asoglu O, Kunduz E, Rahmi Serin K et al (2014) Standardized laparoscopic sphincter preserving total mesorectal excision for rectal cancer: long-term oncologic outcome in 217 unselected consecutive patients. Surg Laparosc Endosc Percutan Tech 24:145–152
doi: 10.1097/SLE.0b013e3182a50e10
pubmed: 24686350
Aliyev V, Arslan NC, Goksoy B, Guven K, Goksel S, Asoglu O (2022) Is robotic da vinci xi® superior to the da vinci si® for sphincter-preserving total mesorectal excision? Outcomes in 150 mid-low rectal cancer patients. J Robot Surg 16(6):1339–1346
doi: 10.1007/s11701-021-01356-8
pubmed: 35107708
Kapiteijn E, Putter H, van de Velde CJ, Cooperative investigators of the Dutch ColoRectal Cancer Group (2002) Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg 89:1142–1149
doi: 10.1046/j.1365-2168.2002.02196.x
Neil C, Helen M, Julie C et al (2018) Exploring and adjusting for potential learning effects in ROLARR: a randomised controlled trial comparing robotic-assisted vs. standard laparoscopic surgery for rectal cancer resection. Trials. https://doi.org/10.1186/s13063-018-2726-0
doi: 10.1186/s13063-018-2726-0
Baik SH, Kwon HY, Kim JS et al (2009) Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study. Ann Surg Oncol 16:1480–1487
doi: 10.1245/s10434-009-0435-3
pubmed: 19290486
Asoglu O, Tokmak H, Bakir B, Aliyev V, Saglam S, Iscan Y, Bademler S, Meric S (2020) Robotic versus laparoscopic sphincter-saving total mesorectal excision for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of long-term outcomes. J Robot Surg 14(3):393–399
doi: 10.1007/s11701-019-01001-5
pubmed: 31313071
Aliyev V, Goksel S, Bakir B, Guven K, Asoglu O (2021) Sphincter-saving robotic total mesorectal excision provides better mesorectal specimen and good oncological local control compared with laparoscopic total mesorectal excision in male patients with mid-low rectal cancer. Surg Technol Int 20(38):160–166. https://doi.org/10.52198/21.STI.38.CR1391 . (PMID: 33537982)
doi: 10.52198/21.STI.38.CR1391
Aliyev V, Piozzi GN, Bulut A, Guven K, Bakir B, Saglam S, Goksel S, Asoglu O (2022) Robotic vs. laparoscopic intersphincteric resection for low rectal cancer: a case matched study reporting a median of 7 year long-term oncological and functional outcomes. Updates Surg. https://doi.org/10.1007/s13304-022-01396-1
doi: 10.1007/s13304-022-01396-1
pubmed: 36198884
Aliyev V, Piozzi GN, Huseynov E, Mustafayev TZ, Kayku V, Goksel S, Asoglu O (2023) Robotic male and laparoscopic female sphincter-preserving total mesorectal excision of mid-low rectal cancer share similar specimen quality, complication rates and long-term oncological outcomes. J Robot Surg 17(4):1637–1644. https://doi.org/10.1007/s11701-023-01558-2 . (Epub 2023 Mar 21 PMID: 36943657)
doi: 10.1007/s11701-023-01558-2
pubmed: 36943657
Aliyev V, Piozzi GN, Shadmanov N, Guven K, Bakır B, Goksel S, Asoglu O (2023) Robotic and laparoscopic sphincter-saving resections have similar peri-operative, oncological and functional outcomes in female patients with rectal cancer. Updates Surg 75(8):2201–2209. https://doi.org/10.1007/s13304-023-01686-2 . (Epub 2023 Nov 13 PMID: 37955804)
doi: 10.1007/s13304-023-01686-2
pubmed: 37955804